DYN FY 2018 Earnings — Dyne Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DYNDyne Therapeutics, Inc.

$3B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$24,000

Operating Income

-$5M

Net Income

-$5M

EPS (Diluted)

$-0.47

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$1,000

Balance Sheet

Total Assets

$8M

Total Liabilities

$13M

Stockholders' Equity

-$5M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$506M	-100.0%
Gross Profit	-$24,000	-$2.4B	+100.0%
Operating Income	-$5M	-$412M	+98.8%
Net Income	-$5M	$76M	-106.3%